PETER S. KIM - 28 Oct 2021 Form 3 Insider Report for Entrada Therapeutics, Inc. (TRDA)

Role
Director
Signature
/s/ Jared Cohen, as Attorney-in-fact
Issuer symbol
TRDA
Transactions as of
28 Oct 2021
Net transactions value
$0
Form type
3
Filing time
28 Oct 2021, 21:03:01 UTC
Next filing
06 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TRDA Common Stock 47,044 28 Oct 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of (i) 8,617 shares of common stock and (ii) 38,427 shares of restricted common stock issued upon early exercise of stock options.

Remarks:

Exhibit 24 - Power of Attorney